Key Players Initiatives: Partnerships and Government initiatives to Fuel the Global smart syringe Market Forward

Published: May 2022

The global smart syringe market is anticipated to grow at a significant CAGR of 10.3% during the forecast period. The key companies across the globe are highly inclined toward the adoption of different growth strategies including capacity expansion, partnerships, government initiatives, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For an instance, in June 2021, Becton, Dickinson, and Company announced that it has secured pandemic orders for 2 billion injection needles and syringes to support COVID-19 vaccine operations. Governments and non-governmental organizations from around the world, including the United States, Australia, Brazil, Canada, France, Germany, India, the Philippines, Saudi Arabia, Spain, and the United Kingdom, collaborated with the global technology company to support vaccine deployment in developing countries.

Browse the full report description “Global Smart Syringe Market Size, Share & Trends Analysis Report, by Products (Active Safety Syringe, Passive Safety Syringe, And Auto-Disable Syringe), By Application (Drug Delivery, Vaccination, And Blood Sample Collection) By End-User (Hospitals and Clinics, Physicians, Diabetes Patients, Psychiatrists, And Others), Forecast Period 2022-2028” at https://www.omrglobal.com/industry-reports/smart-syringes-market   


In addition, Becton, Dickinson and Company has partnered with the US government to invest $70 million in expanding BD's operations and manufacturing capacity in Nebraska. Similarly. In the company's Fraga, Spain production site, a new injection device manufacturing line is being added. The facility is anticipated to ramp up until 2022, increasing device output by 500 million per year to support COVID-19 and other activities for markets such as Europe, the Middle East, and Africa, as well as non-governmental organisations. Over the next four years, the company will invest $1.2 billion to develop and modernise its manufacturing capacity and technologies for pre-filled syringes and sophisticated medication delivery. During a pandemic, this will expand capacity to meet increased demand for pre-filled syringes.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028

Segment Covered- 

  • By Product
  • By Application
  • By End-user

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape-Becton, Dickinson And Company, B. Braun Melsungen Ag, Baxter International Inc., Medtronic, Merck & Company Inc.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

oDeviation from the pre-COVID-19 forecast

oMost affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Smart Syringe Market Report Segment

By Product 

  • Active Safety Syringe
  • Passive Safety Syringe
  • Auto-Disable

By Application 

  • Blood Sample Collection
  • Vaccination 
  • Drug Delivery

By End-User 

  • Hospitals and Clinics
  • Diabetic Patients
  • Physicians
  • Psychiatriststs
  • Others 

Global Smart Syringe Market Report Segment by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/industry-reports/smart-syringes-market